Epidemiology of Hospital Admissions with Influenza during the 2013/2014 Northern Hemisphere Influenza Season: Results from the Global Influenza Hospital Surveillance Network.
Identifieur interne : 000150 ( Main/Exploration ); précédent : 000149; suivant : 000151Epidemiology of Hospital Admissions with Influenza during the 2013/2014 Northern Hemisphere Influenza Season: Results from the Global Influenza Hospital Surveillance Network.
Auteurs : Joan Puig-Barberà [Espagne] ; Angels Natividad-Sancho [Espagne] ; Svetlana Trushakova [Russie] ; Anna Sominina [Russie] ; Maria Pisareva [Russie] ; Meral A. Ciblak [Turquie] ; Selim Badur [Turquie] ; Hongjie Yu [République populaire de Chine] ; Benjamin J. Cowling [République populaire de Chine] ; Clotilde El Guerche-Séblain [France] ; Ainara Mira-Iglesias [Espagne] ; Lidiya Kisteneva [Russie] ; Kirill Stolyarov [Russie] ; Kubra Yurtcu [Turquie] ; Luzhao Feng [République populaire de Chine] ; Xavier L Pez-Labrador [Espagne] ; Elena Burtseva [Russie]Source :
- PloS one [ 1932-6203 ] ; 2016.
Descripteurs français
- KwdFr :
- Admission du patient (MeSH), Adolescent (MeSH), Adulte (MeSH), Adulte d'âge moyen (MeSH), Analyse de regroupements (MeSH), Analyse multifactorielle (MeSH), Chine (MeSH), Comorbidité (MeSH), Complications infectieuses de la grossesse (MeSH), Enfant (MeSH), Enfant d'âge préscolaire (MeSH), Espagne (MeSH), Facteurs de risque (MeSH), Femelle (MeSH), Grippe humaine (épidémiologie), Grossesse (MeSH), Humains (MeSH), Jeune adulte (MeSH), Mâle (MeSH), Nourrisson (MeSH), Nouveau-né (MeSH), Odds ratio (MeSH), Orthomyxoviridae (MeSH), Risque (MeSH), Russie (MeSH), Sujet âgé (MeSH), Sujet âgé de 80 ans ou plus (MeSH), Surveillance épidémiologique (MeSH), Turquie (MeSH), Études prospectives (MeSH).
- MESH :
- épidémiologie : Grippe humaine.
- Admission du patient, Adolescent, Adulte, Adulte d'âge moyen, Analyse de regroupements, Analyse multifactorielle, Chine, Comorbidité, Complications infectieuses de la grossesse, Enfant, Enfant d'âge préscolaire, Espagne, Facteurs de risque, Femelle, Grossesse, Humains, Jeune adulte, Mâle, Nourrisson, Nouveau-né, Odds ratio, Orthomyxoviridae, Risque, Russie, Sujet âgé, Sujet âgé de 80 ans ou plus, Surveillance épidémiologique, Turquie, Études prospectives.
- Wicri :
- geographic : République populaire de Chine, Espagne, Turquie.
English descriptors
- KwdEn :
- Adolescent (MeSH), Adult (MeSH), Aged (MeSH), Aged, 80 and over (MeSH), Child (MeSH), Child, Preschool (MeSH), China (MeSH), Cluster Analysis (MeSH), Comorbidity (MeSH), Epidemiological Monitoring (MeSH), Female (MeSH), Humans (MeSH), Infant (MeSH), Infant, Newborn (MeSH), Influenza, Human (epidemiology), Male (MeSH), Middle Aged (MeSH), Multivariate Analysis (MeSH), Odds Ratio (MeSH), Orthomyxoviridae (MeSH), Outcome Assessment, Health Care (MeSH), Patient Admission (MeSH), Pregnancy (MeSH), Pregnancy Complications, Infectious (MeSH), Prospective Studies (MeSH), Risk (MeSH), Risk Factors (MeSH), Russia (MeSH), Spain (MeSH), Turkey (MeSH), Young Adult (MeSH).
- MESH :
- geographic : China, Russia, Spain, Turkey.
- epidemiology : Influenza, Human.
- Adolescent, Adult, Aged, Aged, 80 and over, Child, Child, Preschool, Cluster Analysis, Comorbidity, Epidemiological Monitoring, Female, Humans, Infant, Infant, Newborn, Male, Middle Aged, Multivariate Analysis, Odds Ratio, Orthomyxoviridae, Outcome Assessment, Health Care, Patient Admission, Pregnancy, Pregnancy Complications, Infectious, Prospective Studies, Risk, Risk Factors, Young Adult.
Abstract
BACKGROUND
The Global Influenza Hospital Surveillance Network was established in 2012 to obtain valid epidemiologic data on hospital admissions with influenza-like illness. Here we describe the epidemiology of admissions with influenza within the Northern Hemisphere sites during the 2013/2014 influenza season, identify risk factors for severe outcomes and complications, and assess the impact of different influenza viruses on clinically relevant outcomes in at-risk populations.
METHODS
Eligible consecutive admissions were screened for inclusion at 19 hospitals in Russia, Turkey, China, and Spain using a prospective, active surveillance approach. Patients that fulfilled a common case definition were enrolled and epidemiological data were collected. Risk factors for hospitalization with laboratory-confirmed influenza were identified by multivariable logistic regression.
FINDINGS
5303 of 9507 consecutive admissions were included in the analysis. Of these, 1086 were influenza positive (534 A(H3N2), 362 A(H1N1), 130 B/Yamagata lineage, 3 B/Victoria lineage, 40 untyped A, and 18 untyped B). The risk of hospitalization with influenza (adjusted odds ratio [95% confidence interval]) was elevated for patients with cardiovascular disease (1.63 [1.33-2.02]), asthma (2.25 [1.67-3.03]), immunosuppression (2.25 [1.23-4.11]), renal disease (2.11 [1.48-3.01]), liver disease (1.94 [1.18-3.19], autoimmune disease (2.97 [1.58-5.59]), and pregnancy (3.84 [2.48-5.94]). Patients without comorbidities accounted for 60% of admissions with influenza. The need for intensive care or in-hospital death was not significantly different between patients with or without influenza. Influenza vaccination was associated with a lower risk of confirmed influenza (adjusted odds ratio = 0.61 [0.48-0.77]).
CONCLUSIONS
Influenza infection was detected among hospital admissions with and without known risk factors. Pregnancy and underlying comorbidity increased the risk of detecting influenza virus in patients hospitalized with influenza-like illness. Our results support influenza vaccination as a measure for reducing the risk of influenza-associated hospital admission.
DOI: 10.1371/journal.pone.0154970
PubMed: 27196667
PubMed Central: PMC4873033
Affiliations:
- Espagne, France, Russie, République populaire de Chine, Turquie
- Auvergne-Rhône-Alpes, Communauté de Madrid, District fédéral central, Rhône-Alpes
- Lyon, Madrid, Moscou, Pékin
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Epidemiology of Hospital Admissions with Influenza during the 2013/2014 Northern Hemisphere Influenza Season: Results from the Global Influenza Hospital Surveillance Network.</title><author><name sortKey="Puig Barbera, Joan" sort="Puig Barbera, Joan" uniqKey="Puig Barbera J" first="Joan" last="Puig-Barberà">Joan Puig-Barberà</name><affiliation wicri:level="1"><nlm:affiliation>Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunidad Valenciana (FISABIO), Valencia, Spain.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunidad Valenciana (FISABIO), Valencia</wicri:regionArea><wicri:noRegion>Valencia</wicri:noRegion></affiliation></author><author><name sortKey="Natividad Sancho, Angels" sort="Natividad Sancho, Angels" uniqKey="Natividad Sancho A" first="Angels" last="Natividad-Sancho">Angels Natividad-Sancho</name><affiliation wicri:level="1"><nlm:affiliation>Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunidad Valenciana (FISABIO), Valencia, Spain.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunidad Valenciana (FISABIO), Valencia</wicri:regionArea><wicri:noRegion>Valencia</wicri:noRegion></affiliation></author><author><name sortKey="Trushakova, Svetlana" sort="Trushakova, Svetlana" uniqKey="Trushakova S" first="Svetlana" last="Trushakova">Svetlana Trushakova</name><affiliation wicri:level="3"><nlm:affiliation>D.I. Ivanovsky Institute of Virology FSBI "N.F. Gamaleya FRCEM" Ministry of Health of Russian Federation, Moscow, Russian Federation.</nlm:affiliation><country xml:lang="fr">Russie</country><wicri:regionArea>D.I. Ivanovsky Institute of Virology FSBI "N.F. Gamaleya FRCEM" Ministry of Health of Russian Federation, Moscow</wicri:regionArea><placeName><settlement type="city">Moscou</settlement><region>District fédéral central</region></placeName></affiliation></author><author><name sortKey="Sominina, Anna" sort="Sominina, Anna" uniqKey="Sominina A" first="Anna" last="Sominina">Anna Sominina</name><affiliation wicri:level="1"><nlm:affiliation>Research Institute of Influenza, St. Petersburg, Russian Federation.</nlm:affiliation><country xml:lang="fr">Russie</country><wicri:regionArea>Research Institute of Influenza, St. Petersburg</wicri:regionArea><wicri:noRegion>St. Petersburg</wicri:noRegion></affiliation></author><author><name sortKey="Pisareva, Maria" sort="Pisareva, Maria" uniqKey="Pisareva M" first="Maria" last="Pisareva">Maria Pisareva</name><affiliation wicri:level="1"><nlm:affiliation>Research Institute of Influenza, St. Petersburg, Russian Federation.</nlm:affiliation><country xml:lang="fr">Russie</country><wicri:regionArea>Research Institute of Influenza, St. Petersburg</wicri:regionArea><wicri:noRegion>St. Petersburg</wicri:noRegion></affiliation></author><author><name sortKey="Ciblak, Meral A" sort="Ciblak, Meral A" uniqKey="Ciblak M" first="Meral A" last="Ciblak">Meral A. Ciblak</name><affiliation wicri:level="1"><nlm:affiliation>National Influenza Reference Laboratory, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.</nlm:affiliation><country xml:lang="fr">Turquie</country><wicri:regionArea>National Influenza Reference Laboratory, Istanbul Faculty of Medicine, Istanbul University, Istanbul</wicri:regionArea><wicri:noRegion>Istanbul</wicri:noRegion></affiliation></author><author><name sortKey="Badur, Selim" sort="Badur, Selim" uniqKey="Badur S" first="Selim" last="Badur">Selim Badur</name><affiliation wicri:level="1"><nlm:affiliation>National Influenza Reference Laboratory, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.</nlm:affiliation><country xml:lang="fr">Turquie</country><wicri:regionArea>National Influenza Reference Laboratory, Istanbul Faculty of Medicine, Istanbul University, Istanbul</wicri:regionArea><wicri:noRegion>Istanbul</wicri:noRegion></affiliation></author><author><name sortKey="Yu, Hongjie" sort="Yu, Hongjie" uniqKey="Yu H" first="Hongjie" last="Yu">Hongjie Yu</name><affiliation wicri:level="3"><nlm:affiliation>Division of Infectious Disease, Key Laboratory of Surveillance and Early-Warning on Infectious Disease, Chinese Center for Disease Control and Prevention, Beijing, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Division of Infectious Disease, Key Laboratory of Surveillance and Early-Warning on Infectious Disease, Chinese Center for Disease Control and Prevention, Beijing</wicri:regionArea><placeName><settlement type="city">Pékin</settlement></placeName></affiliation></author><author><name sortKey="Cowling, Benjamin J" sort="Cowling, Benjamin J" uniqKey="Cowling B" first="Benjamin J" last="Cowling">Benjamin J. Cowling</name><affiliation wicri:level="1"><nlm:affiliation>School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region</wicri:regionArea><wicri:noRegion>Hong Kong Special Administrative Region</wicri:noRegion></affiliation></author><author><name sortKey="El Guerche Seblain, Clotilde" sort="El Guerche Seblain, Clotilde" uniqKey="El Guerche Seblain C" first="Clotilde" last="El Guerche-Séblain">Clotilde El Guerche-Séblain</name><affiliation wicri:level="3"><nlm:affiliation>Sanofi Pasteur, Lyon, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Sanofi Pasteur, Lyon</wicri:regionArea><placeName><region type="region">Auvergne-Rhône-Alpes</region><region type="old region">Rhône-Alpes</region><settlement type="city">Lyon</settlement></placeName></affiliation></author><author><name sortKey="Mira Iglesias, Ainara" sort="Mira Iglesias, Ainara" uniqKey="Mira Iglesias A" first="Ainara" last="Mira-Iglesias">Ainara Mira-Iglesias</name><affiliation wicri:level="1"><nlm:affiliation>Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunidad Valenciana (FISABIO), Valencia, Spain.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunidad Valenciana (FISABIO), Valencia</wicri:regionArea><wicri:noRegion>Valencia</wicri:noRegion></affiliation></author><author><name sortKey="Kisteneva, Lidiya" sort="Kisteneva, Lidiya" uniqKey="Kisteneva L" first="Lidiya" last="Kisteneva">Lidiya Kisteneva</name><affiliation wicri:level="3"><nlm:affiliation>D.I. Ivanovsky Institute of Virology FSBI "N.F. Gamaleya FRCEM" Ministry of Health of Russian Federation, Moscow, Russian Federation.</nlm:affiliation><country xml:lang="fr">Russie</country><wicri:regionArea>D.I. Ivanovsky Institute of Virology FSBI "N.F. Gamaleya FRCEM" Ministry of Health of Russian Federation, Moscow</wicri:regionArea><placeName><settlement type="city">Moscou</settlement><region>District fédéral central</region></placeName></affiliation></author><author><name sortKey="Stolyarov, Kirill" sort="Stolyarov, Kirill" uniqKey="Stolyarov K" first="Kirill" last="Stolyarov">Kirill Stolyarov</name><affiliation wicri:level="1"><nlm:affiliation>Research Institute of Influenza, St. Petersburg, Russian Federation.</nlm:affiliation><country xml:lang="fr">Russie</country><wicri:regionArea>Research Institute of Influenza, St. Petersburg</wicri:regionArea><wicri:noRegion>St. Petersburg</wicri:noRegion></affiliation></author><author><name sortKey="Yurtcu, Kubra" sort="Yurtcu, Kubra" uniqKey="Yurtcu K" first="Kubra" last="Yurtcu">Kubra Yurtcu</name><affiliation wicri:level="1"><nlm:affiliation>National Influenza Reference Laboratory, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.</nlm:affiliation><country xml:lang="fr">Turquie</country><wicri:regionArea>National Influenza Reference Laboratory, Istanbul Faculty of Medicine, Istanbul University, Istanbul</wicri:regionArea><wicri:noRegion>Istanbul</wicri:noRegion></affiliation></author><author><name sortKey="Feng, Luzhao" sort="Feng, Luzhao" uniqKey="Feng L" first="Luzhao" last="Feng">Luzhao Feng</name><affiliation wicri:level="3"><nlm:affiliation>Division of Infectious Disease, Key Laboratory of Surveillance and Early-Warning on Infectious Disease, Chinese Center for Disease Control and Prevention, Beijing, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Division of Infectious Disease, Key Laboratory of Surveillance and Early-Warning on Infectious Disease, Chinese Center for Disease Control and Prevention, Beijing</wicri:regionArea><placeName><settlement type="city">Pékin</settlement></placeName></affiliation></author><author><name sortKey="L Pez Labrador, Xavier" sort="L Pez Labrador, Xavier" uniqKey="L Pez Labrador X" first="Xavier" last="L Pez-Labrador">Xavier L Pez-Labrador</name><affiliation wicri:level="1"><nlm:affiliation>Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunidad Valenciana (FISABIO), Valencia, Spain.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunidad Valenciana (FISABIO), Valencia</wicri:regionArea><wicri:noRegion>Valencia</wicri:noRegion></affiliation><affiliation wicri:level="3"><nlm:affiliation>Centro de Investigación Biomédica en Epidemiología y Salud Publica (CIBER-ESP), Instituto de Salud Carlos III, Madrid, Spain.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Centro de Investigación Biomédica en Epidemiología y Salud Publica (CIBER-ESP), Instituto de Salud Carlos III, Madrid</wicri:regionArea><placeName><settlement type="city">Madrid</settlement><region nuts="2" type="region">Communauté de Madrid</region></placeName></affiliation></author><author><name sortKey="Burtseva, Elena" sort="Burtseva, Elena" uniqKey="Burtseva E" first="Elena" last="Burtseva">Elena Burtseva</name><affiliation wicri:level="3"><nlm:affiliation>D.I. Ivanovsky Institute of Virology FSBI "N.F. Gamaleya FRCEM" Ministry of Health of Russian Federation, Moscow, Russian Federation.</nlm:affiliation><country xml:lang="fr">Russie</country><wicri:regionArea>D.I. Ivanovsky Institute of Virology FSBI "N.F. Gamaleya FRCEM" Ministry of Health of Russian Federation, Moscow</wicri:regionArea><placeName><settlement type="city">Moscou</settlement><region>District fédéral central</region></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2016">2016</date><idno type="RBID">pubmed:27196667</idno><idno type="pmid">27196667</idno><idno type="doi">10.1371/journal.pone.0154970</idno><idno type="pmc">PMC4873033</idno><idno type="wicri:Area/Main/Corpus">00131</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">00131</idno><idno type="wicri:Area/Main/Curation">000131</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000131</idno><idno type="wicri:Area/Main/Exploration">000131</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Epidemiology of Hospital Admissions with Influenza during the 2013/2014 Northern Hemisphere Influenza Season: Results from the Global Influenza Hospital Surveillance Network.</title><author><name sortKey="Puig Barbera, Joan" sort="Puig Barbera, Joan" uniqKey="Puig Barbera J" first="Joan" last="Puig-Barberà">Joan Puig-Barberà</name><affiliation wicri:level="1"><nlm:affiliation>Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunidad Valenciana (FISABIO), Valencia, Spain.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunidad Valenciana (FISABIO), Valencia</wicri:regionArea><wicri:noRegion>Valencia</wicri:noRegion></affiliation></author><author><name sortKey="Natividad Sancho, Angels" sort="Natividad Sancho, Angels" uniqKey="Natividad Sancho A" first="Angels" last="Natividad-Sancho">Angels Natividad-Sancho</name><affiliation wicri:level="1"><nlm:affiliation>Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunidad Valenciana (FISABIO), Valencia, Spain.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunidad Valenciana (FISABIO), Valencia</wicri:regionArea><wicri:noRegion>Valencia</wicri:noRegion></affiliation></author><author><name sortKey="Trushakova, Svetlana" sort="Trushakova, Svetlana" uniqKey="Trushakova S" first="Svetlana" last="Trushakova">Svetlana Trushakova</name><affiliation wicri:level="3"><nlm:affiliation>D.I. Ivanovsky Institute of Virology FSBI "N.F. Gamaleya FRCEM" Ministry of Health of Russian Federation, Moscow, Russian Federation.</nlm:affiliation><country xml:lang="fr">Russie</country><wicri:regionArea>D.I. Ivanovsky Institute of Virology FSBI "N.F. Gamaleya FRCEM" Ministry of Health of Russian Federation, Moscow</wicri:regionArea><placeName><settlement type="city">Moscou</settlement><region>District fédéral central</region></placeName></affiliation></author><author><name sortKey="Sominina, Anna" sort="Sominina, Anna" uniqKey="Sominina A" first="Anna" last="Sominina">Anna Sominina</name><affiliation wicri:level="1"><nlm:affiliation>Research Institute of Influenza, St. Petersburg, Russian Federation.</nlm:affiliation><country xml:lang="fr">Russie</country><wicri:regionArea>Research Institute of Influenza, St. Petersburg</wicri:regionArea><wicri:noRegion>St. Petersburg</wicri:noRegion></affiliation></author><author><name sortKey="Pisareva, Maria" sort="Pisareva, Maria" uniqKey="Pisareva M" first="Maria" last="Pisareva">Maria Pisareva</name><affiliation wicri:level="1"><nlm:affiliation>Research Institute of Influenza, St. Petersburg, Russian Federation.</nlm:affiliation><country xml:lang="fr">Russie</country><wicri:regionArea>Research Institute of Influenza, St. Petersburg</wicri:regionArea><wicri:noRegion>St. Petersburg</wicri:noRegion></affiliation></author><author><name sortKey="Ciblak, Meral A" sort="Ciblak, Meral A" uniqKey="Ciblak M" first="Meral A" last="Ciblak">Meral A. Ciblak</name><affiliation wicri:level="1"><nlm:affiliation>National Influenza Reference Laboratory, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.</nlm:affiliation><country xml:lang="fr">Turquie</country><wicri:regionArea>National Influenza Reference Laboratory, Istanbul Faculty of Medicine, Istanbul University, Istanbul</wicri:regionArea><wicri:noRegion>Istanbul</wicri:noRegion></affiliation></author><author><name sortKey="Badur, Selim" sort="Badur, Selim" uniqKey="Badur S" first="Selim" last="Badur">Selim Badur</name><affiliation wicri:level="1"><nlm:affiliation>National Influenza Reference Laboratory, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.</nlm:affiliation><country xml:lang="fr">Turquie</country><wicri:regionArea>National Influenza Reference Laboratory, Istanbul Faculty of Medicine, Istanbul University, Istanbul</wicri:regionArea><wicri:noRegion>Istanbul</wicri:noRegion></affiliation></author><author><name sortKey="Yu, Hongjie" sort="Yu, Hongjie" uniqKey="Yu H" first="Hongjie" last="Yu">Hongjie Yu</name><affiliation wicri:level="3"><nlm:affiliation>Division of Infectious Disease, Key Laboratory of Surveillance and Early-Warning on Infectious Disease, Chinese Center for Disease Control and Prevention, Beijing, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Division of Infectious Disease, Key Laboratory of Surveillance and Early-Warning on Infectious Disease, Chinese Center for Disease Control and Prevention, Beijing</wicri:regionArea><placeName><settlement type="city">Pékin</settlement></placeName></affiliation></author><author><name sortKey="Cowling, Benjamin J" sort="Cowling, Benjamin J" uniqKey="Cowling B" first="Benjamin J" last="Cowling">Benjamin J. Cowling</name><affiliation wicri:level="1"><nlm:affiliation>School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region</wicri:regionArea><wicri:noRegion>Hong Kong Special Administrative Region</wicri:noRegion></affiliation></author><author><name sortKey="El Guerche Seblain, Clotilde" sort="El Guerche Seblain, Clotilde" uniqKey="El Guerche Seblain C" first="Clotilde" last="El Guerche-Séblain">Clotilde El Guerche-Séblain</name><affiliation wicri:level="3"><nlm:affiliation>Sanofi Pasteur, Lyon, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Sanofi Pasteur, Lyon</wicri:regionArea><placeName><region type="region">Auvergne-Rhône-Alpes</region><region type="old region">Rhône-Alpes</region><settlement type="city">Lyon</settlement></placeName></affiliation></author><author><name sortKey="Mira Iglesias, Ainara" sort="Mira Iglesias, Ainara" uniqKey="Mira Iglesias A" first="Ainara" last="Mira-Iglesias">Ainara Mira-Iglesias</name><affiliation wicri:level="1"><nlm:affiliation>Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunidad Valenciana (FISABIO), Valencia, Spain.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunidad Valenciana (FISABIO), Valencia</wicri:regionArea><wicri:noRegion>Valencia</wicri:noRegion></affiliation></author><author><name sortKey="Kisteneva, Lidiya" sort="Kisteneva, Lidiya" uniqKey="Kisteneva L" first="Lidiya" last="Kisteneva">Lidiya Kisteneva</name><affiliation wicri:level="3"><nlm:affiliation>D.I. Ivanovsky Institute of Virology FSBI "N.F. Gamaleya FRCEM" Ministry of Health of Russian Federation, Moscow, Russian Federation.</nlm:affiliation><country xml:lang="fr">Russie</country><wicri:regionArea>D.I. Ivanovsky Institute of Virology FSBI "N.F. Gamaleya FRCEM" Ministry of Health of Russian Federation, Moscow</wicri:regionArea><placeName><settlement type="city">Moscou</settlement><region>District fédéral central</region></placeName></affiliation></author><author><name sortKey="Stolyarov, Kirill" sort="Stolyarov, Kirill" uniqKey="Stolyarov K" first="Kirill" last="Stolyarov">Kirill Stolyarov</name><affiliation wicri:level="1"><nlm:affiliation>Research Institute of Influenza, St. Petersburg, Russian Federation.</nlm:affiliation><country xml:lang="fr">Russie</country><wicri:regionArea>Research Institute of Influenza, St. Petersburg</wicri:regionArea><wicri:noRegion>St. Petersburg</wicri:noRegion></affiliation></author><author><name sortKey="Yurtcu, Kubra" sort="Yurtcu, Kubra" uniqKey="Yurtcu K" first="Kubra" last="Yurtcu">Kubra Yurtcu</name><affiliation wicri:level="1"><nlm:affiliation>National Influenza Reference Laboratory, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.</nlm:affiliation><country xml:lang="fr">Turquie</country><wicri:regionArea>National Influenza Reference Laboratory, Istanbul Faculty of Medicine, Istanbul University, Istanbul</wicri:regionArea><wicri:noRegion>Istanbul</wicri:noRegion></affiliation></author><author><name sortKey="Feng, Luzhao" sort="Feng, Luzhao" uniqKey="Feng L" first="Luzhao" last="Feng">Luzhao Feng</name><affiliation wicri:level="3"><nlm:affiliation>Division of Infectious Disease, Key Laboratory of Surveillance and Early-Warning on Infectious Disease, Chinese Center for Disease Control and Prevention, Beijing, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Division of Infectious Disease, Key Laboratory of Surveillance and Early-Warning on Infectious Disease, Chinese Center for Disease Control and Prevention, Beijing</wicri:regionArea><placeName><settlement type="city">Pékin</settlement></placeName></affiliation></author><author><name sortKey="L Pez Labrador, Xavier" sort="L Pez Labrador, Xavier" uniqKey="L Pez Labrador X" first="Xavier" last="L Pez-Labrador">Xavier L Pez-Labrador</name><affiliation wicri:level="1"><nlm:affiliation>Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunidad Valenciana (FISABIO), Valencia, Spain.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunidad Valenciana (FISABIO), Valencia</wicri:regionArea><wicri:noRegion>Valencia</wicri:noRegion></affiliation><affiliation wicri:level="3"><nlm:affiliation>Centro de Investigación Biomédica en Epidemiología y Salud Publica (CIBER-ESP), Instituto de Salud Carlos III, Madrid, Spain.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Centro de Investigación Biomédica en Epidemiología y Salud Publica (CIBER-ESP), Instituto de Salud Carlos III, Madrid</wicri:regionArea><placeName><settlement type="city">Madrid</settlement><region nuts="2" type="region">Communauté de Madrid</region></placeName></affiliation></author><author><name sortKey="Burtseva, Elena" sort="Burtseva, Elena" uniqKey="Burtseva E" first="Elena" last="Burtseva">Elena Burtseva</name><affiliation wicri:level="3"><nlm:affiliation>D.I. Ivanovsky Institute of Virology FSBI "N.F. Gamaleya FRCEM" Ministry of Health of Russian Federation, Moscow, Russian Federation.</nlm:affiliation><country xml:lang="fr">Russie</country><wicri:regionArea>D.I. Ivanovsky Institute of Virology FSBI "N.F. Gamaleya FRCEM" Ministry of Health of Russian Federation, Moscow</wicri:regionArea><placeName><settlement type="city">Moscou</settlement><region>District fédéral central</region></placeName></affiliation></author></analytic><series><title level="j">PloS one</title><idno type="eISSN">1932-6203</idno><imprint><date when="2016" type="published">2016</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent (MeSH)</term><term>Adult (MeSH)</term><term>Aged (MeSH)</term><term>Aged, 80 and over (MeSH)</term><term>Child (MeSH)</term><term>Child, Preschool (MeSH)</term><term>China (MeSH)</term><term>Cluster Analysis (MeSH)</term><term>Comorbidity (MeSH)</term><term>Epidemiological Monitoring (MeSH)</term><term>Female (MeSH)</term><term>Humans (MeSH)</term><term>Infant (MeSH)</term><term>Infant, Newborn (MeSH)</term><term>Influenza, Human (epidemiology)</term><term>Male (MeSH)</term><term>Middle Aged (MeSH)</term><term>Multivariate Analysis (MeSH)</term><term>Odds Ratio (MeSH)</term><term>Orthomyxoviridae (MeSH)</term><term>Outcome Assessment, Health Care (MeSH)</term><term>Patient Admission (MeSH)</term><term>Pregnancy (MeSH)</term><term>Pregnancy Complications, Infectious (MeSH)</term><term>Prospective Studies (MeSH)</term><term>Risk (MeSH)</term><term>Risk Factors (MeSH)</term><term>Russia (MeSH)</term><term>Spain (MeSH)</term><term>Turkey (MeSH)</term><term>Young Adult (MeSH)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Admission du patient (MeSH)</term><term>Adolescent (MeSH)</term><term>Adulte (MeSH)</term><term>Adulte d'âge moyen (MeSH)</term><term>Analyse de regroupements (MeSH)</term><term>Analyse multifactorielle (MeSH)</term><term>Chine (MeSH)</term><term>Comorbidité (MeSH)</term><term>Complications infectieuses de la grossesse (MeSH)</term><term>Enfant (MeSH)</term><term>Enfant d'âge préscolaire (MeSH)</term><term>Espagne (MeSH)</term><term>Facteurs de risque (MeSH)</term><term>Femelle (MeSH)</term><term>Grippe humaine (épidémiologie)</term><term>Grossesse (MeSH)</term><term>Humains (MeSH)</term><term>Jeune adulte (MeSH)</term><term>Mâle (MeSH)</term><term>Nourrisson (MeSH)</term><term>Nouveau-né (MeSH)</term><term>Odds ratio (MeSH)</term><term>Orthomyxoviridae (MeSH)</term><term>Risque (MeSH)</term><term>Russie (MeSH)</term><term>Sujet âgé (MeSH)</term><term>Sujet âgé de 80 ans ou plus (MeSH)</term><term>Surveillance épidémiologique (MeSH)</term><term>Turquie (MeSH)</term><term>Études prospectives (MeSH)</term></keywords><keywords scheme="MESH" type="geographic" xml:lang="en"><term>China</term><term>Russia</term><term>Spain</term><term>Turkey</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Grippe humaine</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adolescent</term><term>Adult</term><term>Aged</term><term>Aged, 80 and over</term><term>Child</term><term>Child, Preschool</term><term>Cluster Analysis</term><term>Comorbidity</term><term>Epidemiological Monitoring</term><term>Female</term><term>Humans</term><term>Infant</term><term>Infant, Newborn</term><term>Male</term><term>Middle Aged</term><term>Multivariate Analysis</term><term>Odds Ratio</term><term>Orthomyxoviridae</term><term>Outcome Assessment, Health Care</term><term>Patient Admission</term><term>Pregnancy</term><term>Pregnancy Complications, Infectious</term><term>Prospective Studies</term><term>Risk</term><term>Risk Factors</term><term>Young Adult</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Admission du patient</term><term>Adolescent</term><term>Adulte</term><term>Adulte d'âge moyen</term><term>Analyse de regroupements</term><term>Analyse multifactorielle</term><term>Chine</term><term>Comorbidité</term><term>Complications infectieuses de la grossesse</term><term>Enfant</term><term>Enfant d'âge préscolaire</term><term>Espagne</term><term>Facteurs de risque</term><term>Femelle</term><term>Grossesse</term><term>Humains</term><term>Jeune adulte</term><term>Mâle</term><term>Nourrisson</term><term>Nouveau-né</term><term>Odds ratio</term><term>Orthomyxoviridae</term><term>Risque</term><term>Russie</term><term>Sujet âgé</term><term>Sujet âgé de 80 ans ou plus</term><term>Surveillance épidémiologique</term><term>Turquie</term><term>Études prospectives</term></keywords><keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>République populaire de Chine</term><term>Espagne</term><term>Turquie</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p><b>BACKGROUND</b></p><p>The Global Influenza Hospital Surveillance Network was established in 2012 to obtain valid epidemiologic data on hospital admissions with influenza-like illness. Here we describe the epidemiology of admissions with influenza within the Northern Hemisphere sites during the 2013/2014 influenza season, identify risk factors for severe outcomes and complications, and assess the impact of different influenza viruses on clinically relevant outcomes in at-risk populations.</p></div><div type="abstract" xml:lang="en"><p><b>METHODS</b></p><p>Eligible consecutive admissions were screened for inclusion at 19 hospitals in Russia, Turkey, China, and Spain using a prospective, active surveillance approach. Patients that fulfilled a common case definition were enrolled and epidemiological data were collected. Risk factors for hospitalization with laboratory-confirmed influenza were identified by multivariable logistic regression.</p></div><div type="abstract" xml:lang="en"><p><b>FINDINGS</b></p><p>5303 of 9507 consecutive admissions were included in the analysis. Of these, 1086 were influenza positive (534 A(H3N2), 362 A(H1N1), 130 B/Yamagata lineage, 3 B/Victoria lineage, 40 untyped A, and 18 untyped B). The risk of hospitalization with influenza (adjusted odds ratio [95% confidence interval]) was elevated for patients with cardiovascular disease (1.63 [1.33-2.02]), asthma (2.25 [1.67-3.03]), immunosuppression (2.25 [1.23-4.11]), renal disease (2.11 [1.48-3.01]), liver disease (1.94 [1.18-3.19], autoimmune disease (2.97 [1.58-5.59]), and pregnancy (3.84 [2.48-5.94]). Patients without comorbidities accounted for 60% of admissions with influenza. The need for intensive care or in-hospital death was not significantly different between patients with or without influenza. Influenza vaccination was associated with a lower risk of confirmed influenza (adjusted odds ratio = 0.61 [0.48-0.77]).</p></div><div type="abstract" xml:lang="en"><p><b>CONCLUSIONS</b></p><p>Influenza infection was detected among hospital admissions with and without known risk factors. Pregnancy and underlying comorbidity increased the risk of detecting influenza virus in patients hospitalized with influenza-like illness. Our results support influenza vaccination as a measure for reducing the risk of influenza-associated hospital admission.</p></div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">27196667</PMID><DateCompleted><Year>2017</Year><Month>07</Month><Day>10</Day></DateCompleted><DateRevised><Year>2019</Year><Month>12</Month><Day>10</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>5</Issue><PubDate><Year>2016</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS ONE</ISOAbbreviation></Journal><ArticleTitle>Epidemiology of Hospital Admissions with Influenza during the 2013/2014 Northern Hemisphere Influenza Season: Results from the Global Influenza Hospital Surveillance Network.</ArticleTitle><Pagination><MedlinePgn>e0154970</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0154970</ELocationID><Abstract><AbstractText Label="BACKGROUND">The Global Influenza Hospital Surveillance Network was established in 2012 to obtain valid epidemiologic data on hospital admissions with influenza-like illness. Here we describe the epidemiology of admissions with influenza within the Northern Hemisphere sites during the 2013/2014 influenza season, identify risk factors for severe outcomes and complications, and assess the impact of different influenza viruses on clinically relevant outcomes in at-risk populations.</AbstractText><AbstractText Label="METHODS">Eligible consecutive admissions were screened for inclusion at 19 hospitals in Russia, Turkey, China, and Spain using a prospective, active surveillance approach. Patients that fulfilled a common case definition were enrolled and epidemiological data were collected. Risk factors for hospitalization with laboratory-confirmed influenza were identified by multivariable logistic regression.</AbstractText><AbstractText Label="FINDINGS">5303 of 9507 consecutive admissions were included in the analysis. Of these, 1086 were influenza positive (534 A(H3N2), 362 A(H1N1), 130 B/Yamagata lineage, 3 B/Victoria lineage, 40 untyped A, and 18 untyped B). The risk of hospitalization with influenza (adjusted odds ratio [95% confidence interval]) was elevated for patients with cardiovascular disease (1.63 [1.33-2.02]), asthma (2.25 [1.67-3.03]), immunosuppression (2.25 [1.23-4.11]), renal disease (2.11 [1.48-3.01]), liver disease (1.94 [1.18-3.19], autoimmune disease (2.97 [1.58-5.59]), and pregnancy (3.84 [2.48-5.94]). Patients without comorbidities accounted for 60% of admissions with influenza. The need for intensive care or in-hospital death was not significantly different between patients with or without influenza. Influenza vaccination was associated with a lower risk of confirmed influenza (adjusted odds ratio = 0.61 [0.48-0.77]).</AbstractText><AbstractText Label="CONCLUSIONS">Influenza infection was detected among hospital admissions with and without known risk factors. Pregnancy and underlying comorbidity increased the risk of detecting influenza virus in patients hospitalized with influenza-like illness. Our results support influenza vaccination as a measure for reducing the risk of influenza-associated hospital admission.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Puig-Barberà</LastName><ForeName>Joan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunidad Valenciana (FISABIO), Valencia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Natividad-Sancho</LastName><ForeName>Angels</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunidad Valenciana (FISABIO), Valencia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Trushakova</LastName><ForeName>Svetlana</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>D.I. Ivanovsky Institute of Virology FSBI "N.F. Gamaleya FRCEM" Ministry of Health of Russian Federation, Moscow, Russian Federation.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sominina</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Research Institute of Influenza, St. Petersburg, Russian Federation.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pisareva</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Research Institute of Influenza, St. Petersburg, Russian Federation.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ciblak</LastName><ForeName>Meral A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>National Influenza Reference Laboratory, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Badur</LastName><ForeName>Selim</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>National Influenza Reference Laboratory, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Hongjie</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Division of Infectious Disease, Key Laboratory of Surveillance and Early-Warning on Infectious Disease, Chinese Center for Disease Control and Prevention, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cowling</LastName><ForeName>Benjamin J</ForeName><Initials>BJ</Initials><AffiliationInfo><Affiliation>School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>El Guerche-Séblain</LastName><ForeName>Clotilde</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Sanofi Pasteur, Lyon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mira-Iglesias</LastName><ForeName>Ainara</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunidad Valenciana (FISABIO), Valencia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kisteneva</LastName><ForeName>Lidiya</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>D.I. Ivanovsky Institute of Virology FSBI "N.F. Gamaleya FRCEM" Ministry of Health of Russian Federation, Moscow, Russian Federation.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stolyarov</LastName><ForeName>Kirill</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Research Institute of Influenza, St. Petersburg, Russian Federation.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yurtcu</LastName><ForeName>Kubra</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>National Influenza Reference Laboratory, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Feng</LastName><ForeName>Luzhao</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Division of Infectious Disease, Key Laboratory of Surveillance and Early-Warning on Infectious Disease, Chinese Center for Disease Control and Prevention, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>López-Labrador</LastName><ForeName>Xavier</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunidad Valenciana (FISABIO), Valencia, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centro de Investigación Biomédica en Epidemiología y Salud Publica (CIBER-ESP), Instituto de Salud Carlos III, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Burtseva</LastName><ForeName>Elena</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>D.I. Ivanovsky Institute of Virology FSBI "N.F. Gamaleya FRCEM" Ministry of Health of Russian Federation, Moscow, Russian Federation.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>Global Influenza Hospital Surveillance Study Group (GIHSN)</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>05</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016000" MajorTopicYN="N">Cluster Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015897" MajorTopicYN="N">Comorbidity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D062665" MajorTopicYN="N">Epidemiological Monitoring</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015999" MajorTopicYN="N">Multivariate Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016017" MajorTopicYN="N">Odds Ratio</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009975" MajorTopicYN="N">Orthomyxoviridae</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017063" MajorTopicYN="N">Outcome Assessment, Health Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010343" MajorTopicYN="N">Patient Admission</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011251" MajorTopicYN="N">Pregnancy Complications, Infectious</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012306" MajorTopicYN="N">Risk</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012426" MajorTopicYN="N" Type="Geographic">Russia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013030" MajorTopicYN="N" Type="Geographic">Spain</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014421" MajorTopicYN="N" Type="Geographic">Turkey</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>09</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>04</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>5</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>5</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>7</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27196667</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0154970</ArticleId><ArticleId IdType="pii">PONE-D-15-40424</ArticleId><ArticleId IdType="pmc">PMC4873033</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>J Epidemiol Community Health. 2006 Jan;60(1):7-12</Citation><ArticleIdList><ArticleId IdType="pubmed">16361448</ArticleId></ArticleIdList></Reference><Reference><Citation>Influenza Other Respir Viruses. 2009 Mar;3(2):51-8</Citation><ArticleIdList><ArticleId IdType="pubmed">19496841</ArticleId></ArticleIdList></Reference><Reference><Citation>Stat Med. 2002 Jun 15;21(11):1539-58</Citation><ArticleIdList><ArticleId IdType="pubmed">12111919</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Epidemiol. 1985 Jun;121(6):811-22</Citation><ArticleIdList><ArticleId IdType="pubmed">4014174</ArticleId></ArticleIdList></Reference><Reference><Citation>Public Health Rep. 1986 Mar-Apr;101(2):205-11</Citation><ArticleIdList><ArticleId IdType="pubmed">3083477</ArticleId></ArticleIdList></Reference><Reference><Citation>Western Pac Surveill Response J. 2014 May 20;5(2):23-30</Citation><ArticleIdList><ArticleId IdType="pubmed">25077034</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Paediatr Suppl. 2006 Apr;450:76-85</Citation><ArticleIdList><ArticleId IdType="pubmed">16817681</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2014 Jul 08;9(7):e101785</Citation><ArticleIdList><ArticleId IdType="pubmed">25004134</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 2013 Oct 15;208(8):1305-14</Citation><ArticleIdList><ArticleId IdType="pubmed">23863950</ArticleId></ArticleIdList></Reference><Reference><Citation>Bull World Health Organ. 2007 Sep;85(9):660-7</Citation><ArticleIdList><ArticleId IdType="pubmed">18026621</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Epidemiol. 1998 Dec 1;148(11):1094-102</Citation><ArticleIdList><ArticleId IdType="pubmed">9850132</ArticleId></ArticleIdList></Reference><Reference><Citation>Influenza Other Respir Viruses. 2015 Jul 21;:null</Citation><ArticleIdList><ArticleId IdType="pubmed">26198771</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2007 Jun 28;25(27):5086-96</Citation><ArticleIdList><ArticleId IdType="pubmed">17544181</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2014 Jun 19;9(6):e100497</Citation><ArticleIdList><ArticleId IdType="pubmed">24945510</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 2011 Jun 15;203(12):1739-47</Citation><ArticleIdList><ArticleId IdType="pubmed">21606532</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Microbiol. 2009 Jan;47(1):21-31</Citation><ArticleIdList><ArticleId IdType="pubmed">19020070</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 2003 Sep 6;327(7414):557-60</Citation><ArticleIdList><ArticleId IdType="pubmed">12958120</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Public Health. 2014 Jun 05;14:564</Citation><ArticleIdList><ArticleId IdType="pubmed">24903737</ArticleId></ArticleIdList></Reference><Reference><Citation>Wkly Epidemiol Rec. 2014 Jun 6;89(23):245-56</Citation><ArticleIdList><ArticleId IdType="pubmed">24955460</ArticleId></ArticleIdList></Reference><Reference><Citation>Md State Med J. 1965 Feb;14:61-5</Citation><ArticleIdList><ArticleId IdType="pubmed">14258950</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 2009 Aug 15;200(4):492-500</Citation><ArticleIdList><ArticleId IdType="pubmed">19591575</ArticleId></ArticleIdList></Reference><Reference><Citation>Wkly Epidemiol Rec. 2012 Nov 23;87(47):461-76</Citation><ArticleIdList><ArticleId IdType="pubmed">23210147</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2010 Apr 21;303(15):1517-25</Citation><ArticleIdList><ArticleId IdType="pubmed">20407061</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2012 May 14;30(23):3459-62</Citation><ArticleIdList><ArticleId IdType="pubmed">22446636</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 2013 Aug 23;347:f5061</Citation><ArticleIdList><ArticleId IdType="pubmed">23974637</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2014 Dec 12;32(52):7135-40</Citation><ArticleIdList><ArticleId IdType="pubmed">25454877</ArticleId></ArticleIdList></Reference><Reference><Citation>CMAJ. 2007 Feb 13;176(4):463-8</Citation><ArticleIdList><ArticleId IdType="pubmed">17296958</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2013 Jul 16;8(7):e68760</Citation><ArticleIdList><ArticleId IdType="pubmed">23874754</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Epidemiol. 2002 Jan 15;155(2):176-84</Citation><ArticleIdList><ArticleId IdType="pubmed">11790682</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Microbiol. 2002 Nov;40(11):4337-9</Citation><ArticleIdList><ArticleId IdType="pubmed">12409425</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 2003 Feb 1;36(3):299-305</Citation><ArticleIdList><ArticleId IdType="pubmed">12539071</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Epidemiol. 2010 Aug;63(8):926-31</Citation><ArticleIdList><ArticleId IdType="pubmed">20303710</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 2012 May;54(10):1427-36</Citation><ArticleIdList><ArticleId IdType="pubmed">22495079</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell. 2009 Feb 6;136(3):402-10</Citation><ArticleIdList><ArticleId IdType="pubmed">19203576</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 2014 Jul 15;59(2):166-74</Citation><ArticleIdList><ArticleId IdType="pubmed">24785230</ArticleId></ArticleIdList></Reference><Reference><Citation>Epidemiol Infect. 1993 Feb;110(1):145-60</Citation><ArticleIdList><ArticleId IdType="pubmed">8432318</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 2010 Sep 15;202(6):881-8</Citation><ArticleIdList><ArticleId IdType="pubmed">20677944</ArticleId></ArticleIdList></Reference><Reference><Citation>Epidemiology. 1999 Jan;10(1):37-48</Citation><ArticleIdList><ArticleId IdType="pubmed">9888278</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2011 Jul 22;29 Suppl 2:B56-62</Citation><ArticleIdList><ArticleId IdType="pubmed">21757105</ArticleId></ArticleIdList></Reference><Reference><Citation>Euro Surveill. 2015 Jan 15;20(2):null</Citation><ArticleIdList><ArticleId IdType="pubmed">25613779</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2006 Jul 6;355(1):31-40</Citation><ArticleIdList><ArticleId IdType="pubmed">16822994</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed><affiliations><list><country><li>Espagne</li><li>France</li><li>Russie</li><li>République populaire de Chine</li><li>Turquie</li></country><region><li>Auvergne-Rhône-Alpes</li><li>Communauté de Madrid</li><li>District fédéral central</li><li>Rhône-Alpes</li></region><settlement><li>Lyon</li><li>Madrid</li><li>Moscou</li><li>Pékin</li></settlement></list><tree><country name="Espagne"><noRegion><name sortKey="Puig Barbera, Joan" sort="Puig Barbera, Joan" uniqKey="Puig Barbera J" first="Joan" last="Puig-Barberà">Joan Puig-Barberà</name></noRegion><name sortKey="L Pez Labrador, Xavier" sort="L Pez Labrador, Xavier" uniqKey="L Pez Labrador X" first="Xavier" last="L Pez-Labrador">Xavier L Pez-Labrador</name><name sortKey="L Pez Labrador, Xavier" sort="L Pez Labrador, Xavier" uniqKey="L Pez Labrador X" first="Xavier" last="L Pez-Labrador">Xavier L Pez-Labrador</name><name sortKey="Mira Iglesias, Ainara" sort="Mira Iglesias, Ainara" uniqKey="Mira Iglesias A" first="Ainara" last="Mira-Iglesias">Ainara Mira-Iglesias</name><name sortKey="Natividad Sancho, Angels" sort="Natividad Sancho, Angels" uniqKey="Natividad Sancho A" first="Angels" last="Natividad-Sancho">Angels Natividad-Sancho</name></country><country name="Russie"><region name="District fédéral central"><name sortKey="Trushakova, Svetlana" sort="Trushakova, Svetlana" uniqKey="Trushakova S" first="Svetlana" last="Trushakova">Svetlana Trushakova</name></region><name sortKey="Burtseva, Elena" sort="Burtseva, Elena" uniqKey="Burtseva E" first="Elena" last="Burtseva">Elena Burtseva</name><name sortKey="Kisteneva, Lidiya" sort="Kisteneva, Lidiya" uniqKey="Kisteneva L" first="Lidiya" last="Kisteneva">Lidiya Kisteneva</name><name sortKey="Pisareva, Maria" sort="Pisareva, Maria" uniqKey="Pisareva M" first="Maria" last="Pisareva">Maria Pisareva</name><name sortKey="Sominina, Anna" sort="Sominina, Anna" uniqKey="Sominina A" first="Anna" last="Sominina">Anna Sominina</name><name sortKey="Stolyarov, Kirill" sort="Stolyarov, Kirill" uniqKey="Stolyarov K" first="Kirill" last="Stolyarov">Kirill Stolyarov</name></country><country name="Turquie"><noRegion><name sortKey="Ciblak, Meral A" sort="Ciblak, Meral A" uniqKey="Ciblak M" first="Meral A" last="Ciblak">Meral A. Ciblak</name></noRegion><name sortKey="Badur, Selim" sort="Badur, Selim" uniqKey="Badur S" first="Selim" last="Badur">Selim Badur</name><name sortKey="Yurtcu, Kubra" sort="Yurtcu, Kubra" uniqKey="Yurtcu K" first="Kubra" last="Yurtcu">Kubra Yurtcu</name></country><country name="République populaire de Chine"><noRegion><name sortKey="Yu, Hongjie" sort="Yu, Hongjie" uniqKey="Yu H" first="Hongjie" last="Yu">Hongjie Yu</name></noRegion><name sortKey="Cowling, Benjamin J" sort="Cowling, Benjamin J" uniqKey="Cowling B" first="Benjamin J" last="Cowling">Benjamin J. Cowling</name><name sortKey="Feng, Luzhao" sort="Feng, Luzhao" uniqKey="Feng L" first="Luzhao" last="Feng">Luzhao Feng</name></country><country name="France"><region name="Auvergne-Rhône-Alpes"><name sortKey="El Guerche Seblain, Clotilde" sort="El Guerche Seblain, Clotilde" uniqKey="El Guerche Seblain C" first="Clotilde" last="El Guerche-Séblain">Clotilde El Guerche-Séblain</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/GrippeEspagneV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000150 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000150 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= GrippeEspagneV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:27196667
|texte= Epidemiology of Hospital Admissions with Influenza during the 2013/2014 Northern Hemisphere Influenza Season: Results from the Global Influenza Hospital Surveillance Network.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:27196667" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a GrippeEspagneV1
| This area was generated with Dilib version V0.6.37. |  |